Skip to main content
. 2018 May 7;9:996. doi: 10.3389/fimmu.2018.00996

Figure 4.

Figure 4

Susceptibility to apoptosis in B cells does not differ according to interferon regulatory factor 5 haplotype. Fresh peripheral blood mononuclear cells (PBMCs) were treated with 50 mM CPT-11 for 8 h, stained for CD19, CD14, viability dye, active caspase 3, and analyzed by flow cytometry. (A) Representative dot plots of vehicle and CPT-11-treated PBMCs. (B) Representative dot plots showing proportions of caspase 3+ B cells (top row) and monocytes (bottom row) in risk (left column) and non-risk (right column) haplotype subjects. (C) Proportion of apoptotic CD19+ cells shown combined (top) and separated by haplotype (bottom). (D) Apoptotic CD14+ monocytes shown combined (top) and separated by haplotype (bottom). p < 0.0001 by Wilcoxon matched-pairs signed rank test [(C,D), top], p = ns by Mann–Whitney test for each treatment [(C), bottom], p < 0.05 by Mann–Whitney test for each treatment [(D), bottom].